BRIEF-Fourpoint Resources, Quantum Capital Group And Kayne Anderson To Acquire Ovintiv Uinta Basin Assets For $2 Billion-March 2024-www.financetom.com

BRIEF-Fourpoint Resources, Quantum Capital Group And Kayne Anderson To Acquire Ovintiv Uinta Basin Assets For $2 Billion

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Fourpoint Resources, Quantum Capital Group And Kayne Anderson To Acquire Ovintiv Uinta Basin Assets For $2 Billion

Nov 14, 2024 5:53 AM

Nov 14 (Reuters) - Ovintiv Inc ( OVV ):

* FOURPOINT RESOURCES, QUANTUM CAPITAL GROUP AND KAYNE

ANDERSON TO

ACQUIRE OVINTIV UINTA BASIN ASSETS FOR $2 BILLION

Source text:

Further company coverage:

Previous page： Aecon Acquiring United Engineers & Constructors to Boost North American Nuclear Capability Next page： Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Aecon Acquiring United Engineers & Constructors to Boost North American Nuclear Capability

Nov 3, 2024

08:18 AM EDT, 10/28/2024 (MT Newswires) -- Aecon Group ( AEGXF ) on Monday said that it has entered into a definitive purchase agreement to acquire United Engineers & Constructors, a nuclear and conventional power contractor headquartered in Mount Laurel, New Jersey, from affiliates of CriticalPoint Capital, for US$33 million in cash. United's management and operational teams will join Aecon...

Johnson & Johnson Says Phase 3 Trial of Crohn's Disease Treatment Showed High Remission Rates

Nov 3, 2024

08:19 AM EDT, 10/28/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that results from a phase 3 study of Tremfya as a treatment for Crohn's disease showed high remission rates among tested patients. The first 12 weeks of the trial where Tremfya was administered subcutaneously showed that 56.1% of treated patients achieved clinical remission, J&J said....

Atlas Lithium Receives Approval for Brazil Lithium Mining, Processing Operations

Nov 3, 2024

08:19 AM EDT, 10/28/2024 (MT Newswires) -- Atlas Lithium ( ATLX ) said Monday it has received an operational permit from the Brazilian state of Minas Gerais for the Neves lithium-mining project. With the approval, Atlas has the necessary permits to assemble and operate a lithium processing plant and pursue open-pit mining at one of its deposits. The approval, which...

HF Foods Group Appoints COO Felix Lin as Interim CEO

Nov 3, 2024

08:20 AM EDT, 10/28/2024 (MT Newswires) -- HF Foods Group ( HFFG ) said Monday it appointed Chief Operating Officer Felix Lin as interim chief executive to succeed Peter Zhang. The company said the change in leadership is not due to any disagreement with Zhang, who will remain on the board of directors. No further details on Zhang's departure from...